FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328049371> ?p ?o ?g. }

• W4328049371 endingPage "1975" @default.
• W4328049371 startingPage "1964" @default.
• W4328049371 abstract "Abstract Background Patients with triple-negative breast cancer (TNBC) develop early recurrence. While PARP inhibitors (PARPi) have demonstrated potential in BRCA1/2 -mutant (BRCA MUT ) TNBC, durable responses will likely be achieved if PARPi are used in combination. It is plausible that sequential administration of a potent PARPi like talazoparib in combination with carboplatin can enhance primary tumour and metastasis inhibition in BRCA MUT and BRCA1/2 wild-type (BRCA WT ) TNBCs, and decrease toxicity. Methods We evaluated the impact of the concurrent combination of talazoparib and carboplatin on cell survival in 13 TNBC cell lines. We compared the concurrent and sequential combination upon fork replication, migration and invasion. We also used three orthotopic xenograft models to evaluate primary tumour growth, distant metastasis, and toxicity. Results Concurrent talazoparib and carboplatin was synergistic in 92.3% of TNBC cell lines, independent of BRCA1/2 -mutation status. The sequential combination decreased fork speed in normal cells, but not in TNBC cells. The talazoparib-first sequential combination resulted in a strong reduction in migration (70.4%, P < 0.0001), invasion (56.9%, P < 0.0001), lung micrometastasis (56.4%, P < 0.0001), and less toxicity in a BRCA WT model. Conclusion The sequential combination of talazoparib and carboplatin is an effective approach to inhibit micrometastatic disease, providing rationale for the use of this combination in early TNBC patients." @default.
• W4328049371 created "2023-03-22" @default.
• W4328049371 creator A5006799945 @default.
• W4328049371 creator A5020893248 @default.
• W4328049371 creator A5039264787 @default.
• W4328049371 creator A5064804402 @default.
• W4328049371 creator A5066358109 @default.
• W4328049371 creator A5067135870 @default.
• W4328049371 creator A5071343128 @default.
• W4328049371 creator A5081625917 @default.
• W4328049371 date "2023-03-20" @default.
• W4328049371 modified "2023-10-10" @default.
• W4328049371 title "Sequential targeting of PARP with carboplatin inhibits primary tumour growth and distant metastasis in triple-negative breast cancer" @default.
• W4328049371 cites W1973268287 @default.
• W4328049371 cites W1993043513 @default.
• W4328049371 cites W2012296077 @default.
• W4328049371 cites W2014599726 @default.
• W4328049371 cites W2077945404 @default.
• W4328049371 cites W2086688857 @default.
• W4328049371 cites W2098737737 @default.
• W4328049371 cites W2112241575 @default.
• W4328049371 cites W2117639046 @default.
• W4328049371 cites W2123588904 @default.
• W4328049371 cites W2125123416 @default.
• W4328049371 cites W2135594199 @default.
• W4328049371 cites W2147154862 @default.
• W4328049371 cites W2153798189 @default.
• W4328049371 cites W2170602872 @default.
• W4328049371 cites W2274981669 @default.
• W4328049371 cites W2325495765 @default.
• W4328049371 cites W2437797486 @default.
• W4328049371 cites W2460121490 @default.
• W4328049371 cites W2521351716 @default.
• W4328049371 cites W2539944286 @default.
• W4328049371 cites W2560836545 @default.
• W4328049371 cites W2621271973 @default.
• W4328049371 cites W2744945030 @default.
• W4328049371 cites W2756935441 @default.
• W4328049371 cites W2766810628 @default.
• W4328049371 cites W2788106879 @default.
• W4328049371 cites W2795025555 @default.
• W4328049371 cites W2810748925 @default.
• W4328049371 cites W2886477543 @default.
• W4328049371 cites W2904705904 @default.
• W4328049371 cites W2911100007 @default.
• W4328049371 cites W2949415937 @default.
• W4328049371 cites W2970401899 @default.
• W4328049371 cites W2975028605 @default.
• W4328049371 cites W2998366738 @default.
• W4328049371 cites W3026199219 @default.
• W4328049371 cites W3030957531 @default.
• W4328049371 cites W3037320211 @default.
• W4328049371 cites W3081315565 @default.
• W4328049371 cites W3084114043 @default.
• W4328049371 cites W3096800089 @default.
• W4328049371 cites W3107036092 @default.
• W4328049371 cites W3157242498 @default.
• W4328049371 cites W3165014438 @default.
• W4328049371 cites W3165576985 @default.
• W4328049371 cites W3176275742 @default.
• W4328049371 cites W4200437485 @default.
• W4328049371 cites W4211006558 @default.
• W4328049371 cites W2095749210 @default.
• W4328049371 doi "https://doi.org/10.1038/s41416-023-02226-w" @default.
• W4328049371 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36941406" @default.
• W4328049371 hasPublicationYear "2023" @default.
• W4328049371 type Work @default.
• W4328049371 citedByCount "2" @default.
• W4328049371 countsByYear W43280493712023 @default.
• W4328049371 crossrefType "journal-article" @default.
• W4328049371 hasAuthorship W4328049371A5006799945 @default.
• W4328049371 hasAuthorship W4328049371A5020893248 @default.
• W4328049371 hasAuthorship W4328049371A5039264787 @default.
• W4328049371 hasAuthorship W4328049371A5064804402 @default.
• W4328049371 hasAuthorship W4328049371A5066358109 @default.
• W4328049371 hasAuthorship W4328049371A5067135870 @default.
• W4328049371 hasAuthorship W4328049371A5071343128 @default.
• W4328049371 hasAuthorship W4328049371A5081625917 @default.
• W4328049371 hasBestOaLocation W43280493711 @default.
• W4328049371 hasConcept C104317684 @default.
• W4328049371 hasConcept C121608353 @default.
• W4328049371 hasConcept C126322002 @default.
• W4328049371 hasConcept C143998085 @default.
• W4328049371 hasConcept C182979987 @default.
• W4328049371 hasConcept C2776694085 @default.
• W4328049371 hasConcept C2778123414 @default.
• W4328049371 hasConcept C2778239845 @default.
• W4328049371 hasConcept C2779013556 @default.
• W4328049371 hasConcept C2779138821 @default.
• W4328049371 hasConcept C2780110267 @default.
• W4328049371 hasConcept C2780194787 @default.
• W4328049371 hasConcept C2781451048 @default.
• W4328049371 hasConcept C502942594 @default.
• W4328049371 hasConcept C530470458 @default.
• W4328049371 hasConcept C55493867 @default.
• W4328049371 hasConcept C71924100 @default.
• W4328049371 hasConcept C82381507 @default.
• W4328049371 hasConcept C86803240 @default.

• next